Evaluation of HBV promoters for use in hepatic gene therapy.
about
Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB.Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.Construction, rescue, and characterization of vectors derived from ovine atadenovirus.Time course of gene expression after plasmid DNA gene transfer to the liver.
P2860
Evaluation of HBV promoters for use in hepatic gene therapy.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Evaluation of HBV promoters for use in hepatic gene therapy.
@en
type
label
Evaluation of HBV promoters for use in hepatic gene therapy.
@en
prefLabel
Evaluation of HBV promoters for use in hepatic gene therapy.
@en
P2093
P2860
P1476
Evaluation of HBV promoters for use in hepatic gene therapy.
@en
P2093
P2860
P304
P356
10.1515/BCHM3.1996.377.3.187
P577
1996-03-01T00:00:00Z